A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD
Clinical trial NCT03763877 · COMPLETED
Trial details
- NCT number
- NCT03763877
- Sponsor
- Poxel SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-29
- Primary completion
- 2020-08-03
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.